| EGETIS THERAPEUTICS AB |
| Schweden |
| Gesundheit |
| SE0003815604 / A1JH3B |
| P0F (Frankfurt) |
| FRA:P0F, ETR:P0F, P0F:GR |
| - |
| https://www.egetis.com/ |
|
Egetis Therapeutics AB is a Sweden-based pharmaceutical company specializing in the development of innovative drugs for serious rare diseases with unmet medical needs in the orphan drug segment. Formerly known as PledPharma AB, it rebranded in Decemb..
>Volltext.. |
| 215.5 Mio. EUR |
| 202.68 Mio. EUR |
| 5.86 Mio. EUR |
| - |
| -32.11 Mio. EUR |
| -0.09 EUR |
| 7.17 Mio. EUR |
| 20.23 Mio. EUR |
| -25.04 Mio. EUR |
| 0.9 |
| 43.35% |
| -5.66% |
| - |
| - |
| - |
| - |
| EGETIS, PLEDPHARMA |
| 05.04.26 |
|